Overview

Special Drug Use Investigation of Glucobay OD

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety under practical use of Glucobay OD. A total of 5,000 patients are to be enrolled to the study and assessed during 1 year observation period.
Details
Lead Sponsor:
Bayer
Treatments:
Acarbose